SCHEMBL845328

SCHEMBL845328

CC(C)C(=O)N1CC=C[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3C=CCN3C(=O)C(C)C)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
EPHX2 P34913 1/20 0.34
LMNA P02545 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
FPR3 P25089 1/20 0.34
FPR2 P25090 1/20 0.34
PIN1 Q13526 1/20 0.34
ITGB1 P05556 1/20 0.34
ITGA4 P13612 1/20 0.34
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845097 0.87 NAMPT (0.39) NAMPTPDE3BPDE3AEPHX2LMNA
SCHEMBL845214 0.82 ITGB1 (0.39) NAMPTPDE3BPDE3AEPHX2LMNA
SCHEMBL845331 0.79 PTPN1 (0.41) NAMPTLMNAMEN1KMT2ARAB9A
SCHEMBL844741 0.78 ITGB1 (0.39) NAMPTPDE3BPDE3AEPHX2LMNA
SCHEMBL13272184 0.77 PDE3B (0.34) NAMPTPDE3BPDE3AMEN1KMT2A
SCHEMBL844890 0.75 KCNH2 (0.51) LMNAMEN1KMT2ANPC1ALDH1A1
SCHEMBL845099 0.75 ITGB1 (0.44) PDE3BPDE3ALMNAKMT2AMAPT
SCHEMBL845098 0.74 ITGB1 (0.43) PDE3BPDE3ALMNAKMT2ARAB9A
SCHEMBL845190 0.72 EPHX2 (0.42) EPHX2MEN1KMT2ANPC1RAB9A
SCHEMBL845086 0.72 EPHX2 (0.40) EPHX2MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed